DrugDashboards

DEXTROMETHORPHAN HYDROBROMIDE and BUPROPION HYDROCHLORIDE

DEXTROMETHORPHAN HYDROBROMIDE and BUPROPION HYDROCHLORIDE · DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1; BUPROPION HYDROCHLORIDE 105 mg/1 · Tablet, Multilayer, Extended Release · Patheon Inc.

NDC 66406-0467-00 · 60 BOTTLE in 1 CASE / 21 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for dextromethorphan hydrobromide, bupropion hydrochloride (oral solid) in the next 90 days

sole-source market · price up 6% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of DEXTROMETHORPHAN HYDROBROMIDE and BUPROPION HYDROCHLORIDE (Tablet, Multilayer, Extended Release)

LabelerStrengthFirst seenLast seen
Patheon Inc.DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1; BUPROPION HYDROCHLORIDE 105 mg/1Aug 20, 2026Sep 3, 2026
Patheon Inc.DEXTROMETHORPHAN HYDROBROMIDE 45 mg/1; BUPROPION HYDROCHLORIDE 105 mg/1Aug 20, 2026Sep 3, 2026
Patheon Inc.DEXTROMETHORPHAN HYDROBROMIDE 105 mg/1; BUPROPION HYDROCHLORIDE 30 mg/1Jul 22, 2026Aug 19, 2026
Patheon Inc.DEXTROMETHORPHAN HYDROBROMIDE 105 mg/1; BUPROPION HYDROCHLORIDE 45 mg/1Jul 22, 2026Aug 19, 2026
Patheon Inc.BUPROPION HYDROCHLORIDE 105 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1Jul 15, 2026Jul 15, 2026
Patheon Inc.BUPROPION HYDROCHLORIDE 105 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 45 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "DEXTROMETHORPHAN HYDROBROMIDE and BUPROPION HYDROCHLORIDE — NDC 66406-0467-00," retrieved September 3, 2026, https://drugdashboards.com/drug/66406046700.

Free to cite with attribution — see how the data is put together.